Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial.

<h4>Background</h4>Xpert MTB/RIF is approved for use in tuberculosis (TB) and rifampicin-resistance diagnosis. However, data are limited on the impact of Xpert under routine conditions in settings with high TB burden.<h4>Methods and findings</h4>A pragmatic prospective cluster-randomised trial of Xp...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Helen S Cox, Slindile Mbhele, Neisha Mohess, Andrew Whitelaw, Odelia Muller, Widaad Zemanay, Francesca Little, Virginia Azevedo, John Simpson, Catharina C Boehme, Mark P Nicol
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Public Library of Science (PLoS) 2014-11-01
coleção:	PLoS Medicine
Acesso em linha:	https://doi.org/10.1371/journal.pmed.1001760
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!